2-(4-ethoxybenzyl)-1-diethylaminoethyl-5-isothiocyanatobenzimidazole has been researched along with enkephalin, leucine-2-alanine in 4 studies
| Studies (2-(4-ethoxybenzyl)-1-diethylaminoethyl-5-isothiocyanatobenzimidazole) | Trials (2-(4-ethoxybenzyl)-1-diethylaminoethyl-5-isothiocyanatobenzimidazole) | Recent Studies (post-2010) (2-(4-ethoxybenzyl)-1-diethylaminoethyl-5-isothiocyanatobenzimidazole) | Studies (enkephalin, leucine-2-alanine) | Trials (enkephalin, leucine-2-alanine) | Recent Studies (post-2010) (enkephalin, leucine-2-alanine) |
|---|---|---|---|---|---|
| 14 | 0 | 2 | 1,581 | 23 | 74 |
| Protein | Taxonomy | 2-(4-ethoxybenzyl)-1-diethylaminoethyl-5-isothiocyanatobenzimidazole (IC50) | enkephalin, leucine-2-alanine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.0915 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0017 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.009 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0419 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 1.4691 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.009 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bykov, V; Holaday, JW; Jacobson, AE; Long, JB; Rice, KC; Rothman, RB | 1 |
| Bowen, WD; Burke, TR; Bykov, V; Jacobson, AE; Pert, CB; Rice, KC; Rothman, RB; Schumacher, UK | 1 |
| Burke, TR; Danks, JA; Jacobson, AE; Pert, CB; Rice, KC; Rothman, RB | 2 |
4 other study(ies) available for 2-(4-ethoxybenzyl)-1-diethylaminoethyl-5-isothiocyanatobenzimidazole and enkephalin, leucine-2-alanine
| Article | Year |
|---|---|
Pretreatment of rats with the irreversible mu-receptor antagonist, beta-FNA, fails to prevent naltrexone-induced upregulation of mu-opioid receptors.
Topics: Animals; Brain; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine-2-Alanine; Enkephalins; In Vitro Techniques; Isothiocyanates; Kinetics; Naltrexone; Narcotic Antagonists; Oxymorphone; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, mu; Thiocyanates; Up-Regulation | 1990 |
Preparation of rat brain membranes greatly enriched with either type-I-delta or type-II-delta opiate binding sites using site directed alkylating agents: evidence for a two-site allosteric model.
Topics: Alkylating Agents; Allosteric Regulation; Animals; Brain; Cell Membrane; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Fentanyl; Isothiocyanates; Kinetics; Male; Oxymorphone; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Thiocyanates | 1984 |
Ionic conditions differentially affect 3H-DADL binding to type-I and type-II opiate delta receptors in vitro.
Topics: Animals; Brain; Calcium; Cell Membrane; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Fentanyl; Isothiocyanates; Kinetics; Manganese; Osmolar Concentration; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Sodium; Thiocyanates | 1984 |
Tritiated-6-beta-fluoro-6-desoxy-oxymorphone: a highly selective ligand for the opiate mu receptor whose binding is characterized by low nonspecific binding.
Topics: Animals; Benzomorphans; Brain; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalins; Fentanyl; Hydromorphone; Isothiocyanates; Kinetics; Oxymorphone; Rats; Receptors, Opioid; Receptors, Opioid, mu; Thiocyanates; Tomography, Emission-Computed | 1984 |